Healthlead PCL (BKK:HL)
Thailand · Delayed Price · Currency is THB 6.20
+0.10 (1.64%)
At close: Mar 27, 2026
Healthlead PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 77.86 | 78.26 | 74.68 | 118.23 | 79.66 |
Depreciation & Amortization | 92.71 | 75.32 | 54.58 | 36.79 | 29.75 |
Other Amortization | - | 1.77 | 1.45 | 1.3 | 1.18 |
Loss (Gain) From Sale of Assets | -0.2 | -6.41 | 0.12 | 0.01 | 0.07 |
Asset Writedown & Restructuring Costs | 0.17 | -0.21 | 0.57 | - | - |
Loss (Gain) From Sale of Investments | -7.93 | -6.33 | -6.68 | -2.97 | - |
Other Operating Activities | 11.39 | 7.53 | 1.93 | 11.36 | 6.86 |
Change in Accounts Receivable | -9.1 | -9.47 | -11.05 | -2.89 | -2.91 |
Change in Inventory | -18.33 | -58.71 | -21.73 | -51.92 | -28.97 |
Change in Accounts Payable | 47.89 | 8.71 | 7.04 | 30 | 9.96 |
Change in Other Net Operating Assets | -1.23 | -1.7 | -9.65 | -3.72 | -10.37 |
Operating Cash Flow | 193.24 | 88.76 | 91.26 | 136.2 | 85.25 |
Operating Cash Flow Growth | 117.72% | -2.75% | -33.00% | 59.77% | -12.09% |
Capital Expenditures | -32.19 | -74.56 | -81.54 | -120.13 | -12.81 |
Sale of Property, Plant & Equipment | 0.26 | 0.01 | 0.02 | 0 | 0.02 |
Sale (Purchase) of Intangibles | -1.01 | -3.92 | -1.33 | -0.54 | -2 |
Investment in Securities | 14.5 | -2.92 | -93.48 | -4.02 | - |
Other Investing Activities | -138.58 | -90.5 | 353.61 | -499.82 | 0.04 |
Investing Cash Flow | -157.02 | -171.89 | 177.28 | -624.51 | -14.75 |
Short-Term Debt Repaid | - | - | - | - | -24 |
Long-Term Debt Repaid | -53.89 | -42.21 | -31.12 | -26.78 | -21.5 |
Total Debt Repaid | -53.89 | -42.21 | -31.12 | -26.78 | -45.5 |
Net Debt Issued (Repaid) | -53.89 | -42.21 | -31.12 | -26.78 | -45.5 |
Issuance of Common Stock | - | - | - | - | 683.64 |
Repurchase of Common Stock | -67.32 | - | - | - | - |
Common Dividends Paid | -46.24 | -40.8 | -48.96 | -43.52 | -38 |
Other Financing Activities | -0.01 | -0 | -0 | -0.04 | -0.48 |
Financing Cash Flow | -167.46 | -83.01 | -80.08 | -70.34 | 599.66 |
Net Cash Flow | -131.24 | -166.15 | 188.46 | -558.65 | 670.16 |
Free Cash Flow | 161.05 | 14.2 | 9.72 | 16.07 | 72.44 |
Free Cash Flow Growth | 1034.28% | 46.00% | -39.48% | -77.82% | -13.31% |
Free Cash Flow Margin | 7.09% | 0.71% | 0.59% | 1.04% | 5.96% |
Free Cash Flow Per Share | 0.60 | 0.05 | 0.04 | 0.06 | 0.35 |
Cash Interest Paid | 0.01 | 0 | 0 | 0.04 | 0.48 |
Cash Income Tax Paid | 23.19 | 17.2 | 24.68 | 20.85 | 17.76 |
Levered Free Cash Flow | 141.54 | 3.08 | -16.04 | -8.42 | 43.97 |
Unlevered Free Cash Flow | 151.91 | 11.59 | -10.43 | -4.84 | 47.3 |
Change in Working Capital | 19.24 | -61.17 | -35.39 | -28.52 | -32.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.